All Industries

Top Genomics Companies

107 Genomics companies, sorted by total funding raised.

Arpeggio Bio

Arpeggio Bio develops drugs targeting transcription factors using AI…

Boulder, United States11–50Biotech, Drug Discovery
Series B·$40.2M·Nov 2025
PG
Pathway Genomics

Genomic testing and personalized health services company offering DNA-based health and wellness i...

San Diego, United StatesGenomics, Healthcare
Series E·$40.0M·Jan 2016
PersonalisIPO

Genomic sequencing company enabling precision oncology and cancer biomarker discovery for biophar...

Menlo Park, United States201–500Genomics, Healthcare
Series C·$33.0M·Jan 2015
Form Bio

AI-driven platform for designing and optimizing genetic medicines and genome engineering for biot...

Austin, United States11–50Artificial Intelligence, Biotech
Series A·$30.0M·Sep 2022
bitBiome

Healthcare in Japan

Tokyo, Japan11–50Biotech, Genomics
Extension Round·$28.8M·May 2026
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Seed·$28.5M·Jan 2024
Function Oncology

Develops a CRISPR-powered personalized functional genomics platform to profile patient tumors and...

San Diego, United States1–10Biotech, Diagnostics
Series A·$28.0M·Apr 2023
Talus Bio

Discovering drugs that target the DNA regulome

Seattle, United States11–50Biotech, Drug Discovery
Venture Round·$21.7M·Aug 2024
Volta Labs

Unlocking the utility of genomics for the world.

Cambridge, United States11–50Biotech, Deep Tech
Series A·$20.0M·Mar 2022
Network Bio

Operates a biomedical data securitization platform that creates research-grade datasets from biob...

New York, United States11–50Artificial Intelligence, Data & Analytics
Seed·$19.5M·Feb 2025
InformedDNA

Tech-enabled advisory and benefit management for genetic testing.

St. Petersburg, United States51–200Healthcare, Genomics
Growth Equity·$14.5M·Feb 2020
Champions OncologyIPO

Global preclinical research and clinical specialty testing provider driving excellence in oncolog...

Hackensack, United States201–500Biotech, Drug Discovery
Corporate Round·$14.0M·Mar 2015
Probably Genetic

Patient Intelligence Platform for Genetic Disease

San Francisco, United States1–10Biotech, Genomics
Series A·$10.7M·Mar 2024
NABsys

Electronic genome mapping technology company

Providence, United States11–50Biotech, Genomics
Venture Round·$10.0M·Sep 2011
WhiteLab Genomics

Unleashing the potential of DNA and RNA based therapies using AI

Paris, France11–50Artificial Intelligence, Genomics
Series A·$10.0M·Sep 2022
FLEXOMICS LLC

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

WALTHAM, United States1–10Biotech, Genomics
Grant·$8.4M·Feb 2024
BT
Bina TechnologiesAcquired

Big data platform for centralized management and processing of next-generation sequencing genomic...

Redwood City, United States11–50Bioinformatics, Genomics
Series B·$6.3M·Mar 2013
Clock.Bio

Extending and improving the quality of life by reversing the harmful effects of time in our cells

Cambridge, United Kingdom1–10Biotech, Longevity
Seed·$5.3M·Oct 2024
PHASE GENOMICS, INC.

R&D company with 13 SBIR/STTR awards from Department of Health and Human Services, Department of ...

SEATTLE, United States1–10Biotech, Developer Tools
Grant·$5.0M·Mar 2024
Cambridge Cancer GenomicsAcquired

CCG.ai empowers clinicians to make personalised treatment strategies…

Cambridge, United Kingdom11–50Genomics, Healthcare
Series A·$4.5M·Dec 2018
Sequence Bio

Discovering the true signals of disease to power life-changing drugs.

St. John's, Canada51–200Drug Discovery, Genomics
Seed·$3.9M·Aug 2016
ID GENOMICS SPC

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

SEATTLE, United States1–10Biotech, Genomics
Grant·$3.3M·Aug 2021
MableAcquired

First personalized migraine clinic using genetics and telehealth.

San Francisco, United States1–10Digital Health, Genomics
Seed·$3.3M·Jul 2022
Spiral GeneticsClosed

Large Scale Genomic Data Mining Software

Seattle, United States1–10Genomics, Healthcare
Series A·$3.0M·Mar 2013
XGenomes

XGenomes is building the sequencing technology of the future.

Cambridge, United States1–10Genomics, Healthcare
Seed·$3.0M·Aug 2019